Testosterone
Product Images NDC 0591-2925

9 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Testosterone (NDC 0591-2925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula In Figure 1. Application Sites For Testosterone Gel 1.62% (Image 1)

The Structural Formula In Figure 1. Application Sites For Testosterone Gel 1.62% (Image 1)
Illustration showing the front and side views of a male figure with shaded areas on both upper arms, indicating the application sites for testosterone topical gel.*
FDA Label Image

The Structural Formula Of The Inactive Ingredients In Testosterone Gel 1.62% Are: Carbomer Homopolymer Type C (carbopol 980), Ethyl Alcohol, Isopropyl Myristate, Purified Water, And Sodium Hydroxide. (Image 2)

The Structural Formula Of The Inactive Ingredients In Testosterone Gel 1.62% Are: Carbomer Homopolymer Type C (carbopol 980), Ethyl Alcohol, Isopropyl Myristate, Purified Water, And Sodium Hydroxide. (Image 2)
Chemical structure of testosterone showing its molecular formula C19H28O2 and molecular weight 288.42. The diagram presents the steroid nucleus with associated functional groups.*
FDA Label Image

Figure 2: Mean (±sd) Serum Total Testosterone Concentrations On Day 7 In Patients Following Testosterone Gel 1.62% Once-daily Application Of 81 mg Of Testosterone (n=33) For 7 Days (Image 3)

Figure 2: Mean (±sd) Serum Total Testosterone Concentrations On Day 7 In Patients Following Testosterone Gel 1.62% Once-daily Application Of 81 mg Of Testosterone (n=33) For 7 Days (Image 3)
A line graph showing total testosterone levels (ng/dL) over 24 hours. The graph compares two application sites: upper arms/shoulders and rotation of abdomen and upper arms/shoulders, plotting testosterone concentration at multiple time points from 0 to 24 hours with error bars indicating variability.*
FDA Label Image

Figure 3: Mean (±sd) Steady-state Serum Total Testosterone Concentrations On Day 112 (Image 4)

Figure 3: Mean (±sd) Steady-state Serum Total Testosterone Concentrations On Day 112 (Image 4)
A line graph titled "Day 112" showing mean total testosterone levels (ng/dl) over 24 hours. It compares treatment groups: all active doses of testosterone gel 1.62% and placebo. The y-axis represents testosterone levels with a normal range marked between 300 and 1000 ng/dl. The x-axis represents time in hours from 0 to 24. Error bars indicate standard deviation for each mean value.*
FDA Label Image

Figure 4: Mean (±sd) Steady-state Serum Total Testosterone Concentrations On Day 364 (Image 5)

Figure 4: Mean (±sd) Steady-state Serum Total Testosterone Concentrations On Day 364 (Image 5)
A line graph showing mean total testosterone levels (ng/dl) over 24 hours on day 364 for a group using Testosterone Gel 1.62%. The graph includes error bars representing standard deviation and marks the normal testosterone range between 300 and 1000 ng/dl with upper and lower bound lines.*
FDA Label Image

The Application Sites For Testosterone Gel 1.62% Are The Upper Arms And Shoulders That Will Be Covered By A Short Sleeve T-shirt (see Figure A). (Image 6)

The Application Sites For Testosterone Gel 1.62% Are The Upper Arms And Shoulders That Will Be Covered By A Short Sleeve T-shirt (see Figure A). (Image 6)
Illustration showing the application areas for Testosterone 16.2 mg/g topical gel. Shaded areas on the front and side views of a male torso highlight the shoulders and upper arms as intended sites for gel application.*
FDA Label Image

1 (Image 7)

1 (Image 7)
Packaging label for Testosterone Gel 1.62% (Alcohol 80% v/v) topical gel containing 20.25 mg of testosterone per pump actuation. The label shows product details including multi-dose pump dispensing 60 metered pump actuations, total content of 88 grams, and the manufacturer Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Image 8

Image 8
Packaging label for Testosterone Gel 1.62% (16.2 mg/g) by Actavis Pharma, Inc. The label indicates it is an alcohol-based topical gel supplied in 30 unit-dose packets. It includes usage instructions, warnings about flammability, storage conditions, and pharmacist dispensing information. The label also features the NDC 0591-2925-30 and Teva branding.*
FDA Label Image

Image 9

Image 9
Packaging label for Testosterone Gel 1.62% (16.2 mg/g) containing alcohol 80% v/v, manufactured by Actavis Pharma, Inc. The label displays dosage information, warnings, and directions for topical use, including the NDC 0591-2926-30. It includes usage and storage instructions, a barcode, and details about dispensing the enclosed medication guide in 30 unit-dose packets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.